Cross Country Net Worth

Cross Country Net Worth Breakdown

  CCRN
The net worth of Cross Country Healthcare is the difference between its total assets and liabilities. Cross Country's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Cross Country's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Cross Country's net worth can be used as a measure of its financial health and stability which can help investors to decide if Cross Country is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Cross Country Healthcare stock.

Cross Country Net Worth Analysis

Cross Country's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Cross Country's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Cross Country's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Cross Country's net worth analysis. One common approach is to calculate Cross Country's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Cross Country's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Cross Country's net worth. This approach calculates the present value of Cross Country's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Cross Country's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Cross Country's net worth. This involves comparing Cross Country's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Cross Country's net worth relative to its peers.

Enterprise Value

559.49 Million

To determine if Cross Country is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cross Country's net worth research are outlined below:
Cross Country generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 1.34 B. Net Loss for the year was (14.56 M) with profit before overhead, payroll, taxes, and interest of 274.25 M.
Cross Country has a poor financial position based on the latest SEC disclosures
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Acquisition by Mcdonald Colin Patrick of 2614 shares of Cross Country subject to Rule 16b-3

Cross Country Quarterly Good Will

135.06 Million

Cross Country uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cross Country Healthcare. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cross Country's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Cross Country Target Price Consensus

Cross target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Cross Country's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   8  Hold
Most Cross analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Cross stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Cross Country Healthcare, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Cross Country Target Price Projection

Cross Country's current and average target prices are 14.94 and 17.46, respectively. The current price of Cross Country is the price at which Cross Country Healthcare is currently trading. On the other hand, Cross Country's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Cross Country Market Quote on 23rd of March 2025

Low Price14.7Odds
High Price15.01Odds

14.94

Target Price

Analyst Consensus On Cross Country Target Price

Low Estimate15.89Odds
High Estimate19.38Odds

17.4575

Historical Lowest Forecast  15.89 Target Price  17.46 Highest Forecast  19.38
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Cross Country Healthcare and the information provided on this page.

Know Cross Country's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Cross Country is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cross Country Healthcare backward and forwards among themselves. Cross Country's institutional investor refers to the entity that pools money to purchase Cross Country's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-12-31
754.4 K
Goldman Sachs Group Inc2024-12-31
698 K
Cnh Partners, Llc2024-12-31
597.5 K
Eckert Corp2024-12-31
581 K
Dana Investment Advisors Inc2024-12-31
552.9 K
D. E. Shaw & Co Lp2024-12-31
524.8 K
First Trust Capital Management L.p.2024-12-31
485.6 K
Hsbc Holdings Plc2024-12-31
413.6 K
Millennium Management Llc2024-12-31
405.6 K
Blackrock Inc2024-12-31
2.9 M
Magnetar Financial Llc2024-12-31
2.3 M
Note, although Cross Country's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Cross Country's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 490.22 M.

Market Cap

477.34 Million

Project Cross Country's profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.04)(0.03)
Return On Capital Employed(0.04)(0.03)
Return On Assets(0.02)(0.02)
Return On Equity(0.03)(0.03)
The company has Profit Margin (PM) of (0.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.01) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.01.
When accessing Cross Country's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Cross Country's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cross Country's profitability and make more informed investment decisions.

Evaluate Cross Country's management efficiency

As of the 23rd of March 2025, Return On Tangible Assets is likely to grow to -0.03. In addition to that, Return On Capital Employed is likely to grow to -0.03. At this time, Cross Country's Non Currrent Assets Other are very stable compared to the past year. As of the 23rd of March 2025, Other Current Assets is likely to grow to about 31.6 M, while Total Assets are likely to drop about 487.2 M. Cross Country's management efficiency ratios could be used to measure how well Cross Country manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for Next Year
Book Value Per Share 12.55  9.09 
Tangible Book Value Per Share 7.24  7.60 
Enterprise Value Over EBITDA 132.43  139.05 
Price Book Value Ratio 1.45  1.58 
Enterprise Value Multiple 132.43  139.05 
Price Fair Value 1.45  1.58 
Enterprise Value374.9 M559.5 M
The strategic initiatives led by Cross Country's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue
0.3069
Revenue
1.3 B
Quarterly Revenue Growth
(0.25)
Revenue Per Share
40.265
Return On Equity
(0.03)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cross Country insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cross Country's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cross Country insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Mcdonald Colin Patrick few days ago
Acquisition by Mcdonald Colin Patrick of 2614 shares of Cross Country subject to Rule 16b-3
 
Grieco Cynthia Ann over three months ago
Disposition of 1945 shares by Grieco Cynthia Ann of Cross Country at 17.21 subject to Rule 16b-3
 
Krug Marc S. over three months ago
Disposition of 6000 shares by Krug Marc S. of Cross Country at 19.91 subject to Rule 16b-3
 
Allen Dwayne over six months ago
Acquisition by Allen Dwayne of 9921 shares of Cross Country subject to Rule 16b-3
 
Perlberg Mark C over six months ago
Acquisition by Perlberg Mark C of 9921 shares of Cross Country subject to Rule 16b-3
 
Krug Marc S. over six months ago
Disposition of 1137 shares by Krug Marc S. of Cross Country at 15.05 subject to Rule 16b-3
 
Nevin Janice Elizabeth over six months ago
Disposition of 2150 shares by Nevin Janice Elizabeth of Cross Country at 15.12 subject to Rule 16b-3
 
Mote Karen over six months ago
Disposition of 438 shares by Mote Karen of Cross Country at 18.72 subject to Rule 16b-3
 
Phillip Noe over six months ago
Disposition of 956 shares by Phillip Noe of Cross Country at 14.93 subject to Rule 16b-3
 
Kevin Clark over six months ago
Disposition of 14560 shares by Kevin Clark of Cross Country at 22.32 subject to Rule 16b-3
 
Mcdonald Colin Patrick over six months ago
Disposition of 441 shares by Mcdonald Colin Patrick of Cross Country at 18.72 subject to Rule 16b-3
 
William Burns over six months ago
Acquisition by William Burns of 18573 shares of Cross Country subject to Rule 16b-3

Cross Country Corporate Filings

F4
21st of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
5th of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
5th of February 2025
Other Reports
ViewVerify
22nd of January 2025
Other Reports
ViewVerify
Cross Country time-series forecasting models is one of many Cross Country's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cross Country's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Cross Country Earnings Estimation Breakdown

The calculation of Cross Country's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Cross Country is estimated to be 0.0714 with the future projection ranging from a low of 0.02 to a high of 0.19. Please be aware that this consensus of annual earnings estimates for Cross Country Healthcare is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.04
0.02
Lowest
Expected EPS
0.0714
0.19
Highest

Cross Country Earnings Projection Consensus

Suppose the current estimates of Cross Country's value are higher than the current market price of the Cross Country stock. In this case, investors may conclude that Cross Country is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Cross Country's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2025Current EPS (TTM)
871.74%
0.04
0.0714
-0.44

Cross Country Earnings per Share Projection vs Actual

Actual Earning per Share of Cross Country refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Cross Country Healthcare predict the company's earnings will be in the future. The higher the earnings per share of Cross Country, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Cross Country Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Cross Country, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Cross Country should always be considered in relation to other companies to make a more educated investment decision.

Cross Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Cross Country's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-02-19
2024-12-310.11450.04-0.074565 
2024-11-06
2024-09-300.10.120.0220 
2024-07-31
2024-06-300.130.1-0.0323 
2024-05-01
2024-03-310.170.190.0211 
2024-02-21
2023-12-310.270.290.02
2023-11-01
2023-09-300.410.39-0.02
2023-08-02
2023-06-300.610.690.0813 
2023-05-03
2023-03-310.750.840.0912 
2023-02-22
2022-12-310.891.090.222 
2022-11-02
2022-09-300.951.070.1212 
2022-08-03
2022-06-301.351.40.05
2022-05-04
2022-03-311.311.70.3929 
2022-02-23
2021-12-311.241.40.1612 
2021-11-03
2021-09-300.340.610.2779 
2021-08-04
2021-06-300.40.470.0717 
2021-05-05
2021-03-310.340.580.2470 
2021-02-24
2020-12-310.090.190.1111 
2020-11-04
2020-09-30-0.030.120.15500 
2020-08-05
2020-06-30-0.030.160.19633 
2020-05-07
2020-03-31-0.02-0.010.0150 
2020-03-04
2019-12-310.060.070.0116 
2019-11-05
2019-09-300.010.050.04400 
2019-07-31
2019-06-30-0.00420.010.0142338 
2019-05-01
2019-03-31-0.040.020.06150 
2019-02-27
2018-12-310.02-0.5534-0.57342867 
2018-11-01
2018-09-300.030.02-0.0133 
2018-08-01
2018-06-300.060.05-0.0116 
2018-05-02
2018-03-310.020.060.04200 
2018-02-28
2017-12-310.190.17-0.0210 
2017-11-01
2017-09-300.180.230.0527 
2017-08-02
2017-06-300.090.160.0777 
2017-05-03
2017-03-310.010.050.04400 
2017-03-01
2016-12-310.220.2-0.02
2016-11-02
2016-09-300.150.240.0960 
2016-08-03
2016-06-300.130.160.0323 
2016-05-04
2016-03-310.070.090.0228 
2016-03-09
2015-12-310.190.18-0.01
2015-11-04
2015-09-300.10.230.13130 
2015-08-05
2015-06-300.060.10.0466 
2015-05-06
2015-03-310.030.030.0
2015-03-04
2014-12-310.040.03-0.0125 
2014-11-05
2014-09-300.020.070.05250 
2014-08-06
2014-06-300.010.010.0
2014-05-07
2014-03-31-0.01-0.02-0.01100 
2014-03-05
2013-12-310.01-1.6916-1.701617016 
2013-08-06
2013-06-30-0.01-0.02-0.01100 
2013-03-18
2012-12-31-0.01-0.05-0.04400 
2012-11-06
2012-09-300.02-0.02-0.04200 
2012-08-06
2012-06-300.03-0.08-0.11366 
2012-05-09
2012-03-310.01-0.019-0.029290 
2012-03-05
2011-12-310.050.04-0.0120 
2011-11-02
2011-09-300.040.060.0250 
2011-08-03
2011-06-300.040.050.0125 
2011-05-04
2011-03-310.010.010.0
2011-03-08
2010-12-310.020.020.0
2010-11-01
2010-09-300.030.030.0
2010-08-04
2010-06-300.030.040.0133 
2010-05-05
2010-03-310.020.040.02100 
2010-03-03
2009-12-310.030.050.0266 
2009-11-02
2009-09-300.020.030.0150 
2009-08-05
2009-06-300.050.070.0240 
2009-05-06
2009-03-310.090.10.0111 
2009-03-04
2008-12-310.160.180.0212 
2008-11-03
2008-09-300.20.20.0
2008-08-05
2008-06-300.20.210.01
2008-05-07
2008-03-310.160.190.0318 
2008-03-03
2007-12-310.220.230.01
2007-11-05
2007-09-300.20.220.0210 
2007-08-07
2007-06-300.170.170.0
2007-05-07
2007-03-310.150.150.0
2007-02-12
2006-12-310.190.190.0
2006-11-06
2006-09-300.140.170.0321 
2006-08-07
2006-06-300.150.14-0.01
2006-05-08
2006-03-310.130.140.01
2006-02-13
2005-12-310.170.180.01
2005-11-02
2005-09-300.150.160.01
2005-08-09
2005-06-300.090.140.0555 
2005-05-09
2005-03-310.110.120.01
2005-03-07
2004-12-310.160.180.0212 
2004-11-03
2004-09-300.150.160.01
2004-08-09
2004-06-300.140.160.0214 
2004-05-05
2004-03-310.140.150.01
2004-02-18
2003-12-310.140.160.0214 
2003-11-05
2003-09-300.230.21-0.02
2003-08-06
2003-06-300.220.230.01
2003-05-08
2003-03-310.220.230.01
2003-02-18
2002-12-310.280.280.0
2002-11-04
2002-09-300.260.260.0
2002-08-06
2002-06-300.240.250.01
2002-05-07
2002-03-310.20.220.0210 
2002-02-15
2001-12-310.180.210.0316 

Cross Country Corporate Management

Karen VargaSinkaDirector CommunicationsProfile
Joshua VogelVice RelationsProfile
Colin MSChief OfficerProfile
BA MDivSenior OfficerProfile
MBA JDGroup DeliveryProfile
Daniel WhiteChief OfficerProfile
When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.79)
Earnings Share
(0.44)
Revenue Per Share
40.265
Quarterly Revenue Growth
(0.25)
Return On Assets
(0.01)
The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.